Literature DB >> 3306601

Characterization of rat c-myc and adjacent regions.

K Hayashi, R Makino, H Kawamura, A Arisawa, K Yoneda.   

Abstract

Rat genomic regions covering c-myc were cloned from the DNA of both normal liver and two lines of Morris hepatomas, one of which had c-myc amplification. The three restriction maps showed perfect agreement within the overlapping regions. The 7 kb regions, which included the entire normal rat c-myc and the region 2.2 kb upstream, and one from the hepatomas, were sequenced and found to be identical. The coding regions of exons 2 and 3 were highly conserved between rat, mouse and man, but some differences in amino acids were noted. Exon 1 and the non-coding region of exon 3 showed limited homology between the three species. Rat exon 1 contained several nonsense codons in each frame and no ATG codon, indicating there to be no coding capacity in this exon. The 2.2 kb upstream regions and the introns compared showed unusual conservation between the rat and human genes. Some motifs, previously proposed as having a functional role in human c-myc, were also found in equivalent positions of the rat sequence. Nucleas S1 protection mapping revealed the second promoter to be preferentially used in most tissues or in hepatoma cells, and the second poly A addition signal to be the only one functional in all the RNA sources examined.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3306601      PMCID: PMC306114          DOI: 10.1093/nar/15.16.6419

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  54 in total

1.  Interferon action: RNA cleavage pattern of a (2'-5')oligoadenylate--dependent endonuclease.

Authors:  G Floyd-Smith; E Slattery; P Lengyel
Journal:  Science       Date:  1981-05-29       Impact factor: 47.728

2.  Molecular cloning of the avian myelocytomatosis virus genome and recovery of infectious virus by transfection of chicken cells.

Authors:  B Vennström; C Moscovici; H M Goodman; J M Bishop
Journal:  J Virol       Date:  1981-08       Impact factor: 5.103

Review 3.  Cellular oncogenes and retroviruses.

Authors:  J M Bishop
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

4.  Random subcloning of sonicated DNA: application to shotgun DNA sequence analysis.

Authors:  P L Deininger
Journal:  Anal Biochem       Date:  1983-02-15       Impact factor: 3.365

5.  Identification and nucleotide sequence of a human locus homologous to the v-myc oncogene of avian myelocytomatosis virus MC29.

Authors:  W W Colby; E Y Chen; D H Smith; A D Levinson
Journal:  Nature       Date:  1983-02-24       Impact factor: 49.962

6.  Nuclear location of the putative transforming protein of avian myelocytomatosis virus.

Authors:  H D Abrams; L R Rohrschneider; R N Eisenman
Journal:  Cell       Date:  1982-06       Impact factor: 41.582

7.  Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour.

Authors:  M Schwab; K Alitalo; K H Klempnauer; H E Varmus; J M Bishop; F Gilbert; G Brodeur; M Goldstein; J Trent
Journal:  Nature       Date:  1983 Sep 15-21       Impact factor: 49.962

8.  DNA sequences homologous to vertebrate oncogenes are conserved in Drosophila melanogaster.

Authors:  B Z Shilo; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

9.  Specific binding of a cellular DNA replication protein to the origin of replication of adenovirus DNA.

Authors:  K Nagata; R A Guggenheimer; J Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

10.  Translocation, breakage and truncated transcripts of c-myc oncogene in murine plasmacytomas.

Authors:  L W Stanton; R Watt; K B Marcu
Journal:  Nature       Date:  1983 Jun 2-8       Impact factor: 49.962

View more
  19 in total

1.  Interspecies comparison of c-myc gene in human and rat glioma cell lines.

Authors:  H Shindo; E Tani; N Kochi; K Kaba; T Matsumoto; K Miyaji; Y Yamamoto; J Furuyama
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

2.  Rapid c-myc mRNA degradation does not require (A + U)-rich sequences or complete translation of the mRNA.

Authors:  I A Laird-Offringa; P Elfferich; A J van der Eb
Journal:  Nucleic Acids Res       Date:  1991-05-11       Impact factor: 16.971

3.  The amplification of oligonucleotide themes in the evolution of the myc protooncogene family.

Authors:  J Doskocil
Journal:  J Mol Evol       Date:  1996-05       Impact factor: 2.395

4.  Analysis of polyadenylation site usage of the c-myc oncogene.

Authors:  I A Laird-Offringa; P Elfferich; H J Knaken; J de Ruiter; A J van der Eb
Journal:  Nucleic Acids Res       Date:  1989-08-25       Impact factor: 16.971

5.  The 5' splice site: phylogenetic evolution and variable geometry of association with U1RNA.

Authors:  M Jacob; H Gallinaro
Journal:  Nucleic Acids Res       Date:  1989-03-25       Impact factor: 16.971

6.  Gorilla and orangutan c-myc nucleotide sequences: inference on hominoid phylogeny.

Authors:  K Mohammad-Ali; M E Eladari; F Galibert
Journal:  J Mol Evol       Date:  1995-09       Impact factor: 2.395

7.  A polymorphic variant of human c-Myc: Asn11-->Ser.

Authors:  P G Rothberg; Y M Otto
Journal:  Mamm Genome       Date:  1995-03       Impact factor: 2.957

8.  A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo.

Authors:  R Morishita; G H Gibbons; M Horiuchi; K E Ellison; M Nakama; L Zhang; Y Kaneda; T Ogihara; V J Dzau
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

9.  Cloning and characterization of a c-myc intron binding protein (MIBP1).

Authors:  R Makino; K Akiyama; J Yasuda; S Mashiyama; S Honda; T Sekiya; K Hayashi
Journal:  Nucleic Acids Res       Date:  1994-12-25       Impact factor: 16.971

10.  Structure and expression of B-myc, a new member of the myc gene family.

Authors:  S Ingvarsson; C Asker; H Axelson; G Klein; J Sümegi
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.